Back

Should we avoid transvenous defibrillator therapy?

17 April 2023 (18:00 - 18:15)
Organised by:
Congress Presentation Part of: Defibrillator therapy without a lead in the heart Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2023

About the speaker

Photo
Professor Jeff Healey

Population Health Research Institute, Hamilton (Canada)

3 More presentations in this session

Presentation thumbnail
Has the S-ICD become standard of care?
Professor P. Lambiase (London, GB)
Slides Video
Presentation thumbnail
Modular therapy with S-ICD and leadless pacing
Assistant Professor F. Tjong (Amsterdam, NL)
Slides Video
Presentation thumbnail
Does the substernal ICD meet our needs?
Doctor N. Clementy (Montpellier, FR)
Slides Video

Access the full session

Session thumbnail
Defibrillator therapy without a lead in the heart
Video

The Event

Event poster

EHRA 2023

17 April 2023 18:00 CET
You may be interested in
thumbnail
Congress Presentation
Is the S-ICD safer than the transvenous ICD?
8 April 2024
thumbnail
Congress Presentation
Hot topics in pacing and implantable cardioverter defibrillator.
5 April 2022
thumbnail
Congress Presentation
What is the right defibrillator for my patient?
4 April 2022
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator in primary prevention should be endovascular lead
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources